According to FutureWise analysis, the market for Bariatric Surgery is expected to reach US$ 2,938.08 million by 2030 and is projected to expand at a CAGR of 5.6%.
The gastrointestinal system is operated on during a specific kind of weight-loss surgery called bariatric surgery. Among the options are stomach shortening, stomach stapling, gastric bypass, and gastric bands. This technique is intended to address a co-morbid condition that is linked to morbid obesity. The gastrointestinal system is altered by bariatric surgery devices by limiting the quantity of food that can be absorbed by the stomach and the amount of nutrients that the intestinal tract can absorb. For individuals suffering from severe obesity, as well as others who have severe obesity paired with other obesity-related diseases, bariatric surgery is a safe and effective therapy option.
These procedures identify the metabolic and hormonal changes in hunger (wanting to eat) and satiety (feeling full). Additionally, they assist in enhancing and/or resolving diseases that may develop due to obesity and/or extreme obesity. Bariatric surgery is a well-known and widely-accepted method of treating obesity-related diseases and weight loss. But not everyone is a candidate for bariatric surgery. People must fulfill a number of standards in order to qualify for bariatric surgery. FDA-approved bariatric devices are another option for treating obesity besides bariatric surgery. It is not permissible to use these devices to treat severe obesity.
FutureWise Market Research has published a report that provides an insightful analysis of bariatric surgery devices market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the bariatric surgery devices market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.
Major players included in the Bariatric Surgery Devices Market are:
- Cousin Biotech
- INTUITIVE SURGICAL
- ENDOGASTRIC SOLUTIONS
- ENTEROMEDICS
- Covidien PLC
- USGI Medical
- Olympus
- Johnson And Johnson
- ReShape Medical
- Ethicon-Endosurgery
(Note: The list of the major players will be updated with the latest market scenario and trends)
Recent developments by key players in Bariatric Surgery Devices Market:
In January 2022- In a first-of-its-kind procedure for the Telugu states, Apollo Hospital in Hyderabad, India announced on that it has just completed its first Full Robotic Bariatric surgery. Hibibo Abdulle Mohamed, a Somalian patient 40 years old who weighed a massive 180 kg and had several health issues, underwent the procedure.
The significant increase in obesity poses a hazard to humanity on a worldwide scale. Recently, medical technology has advanced to aid in the fight against the obesity epidemic. A body mass index (BMI) of more than 30 kg/m2 indicates obesity, which is associated with the formation of co-morbid disorders such as type 2 diabetes, hypertension, and sleep apnea. Studies show that overweight and obesity contribute to 2.8 million deaths annually. The traditional method of treating obesity has focused on medications and dietary & activity modifications, which typically yield extremely poor weight loss results. Additionally, there aren't many medications approved for the treatment of obesity and those that may have unfavorable side effects that decrease patient compliance. The IFSO urges individuals who have not responded to medical treatment for obesity to consider having bariatric surgery as a treatment option. Bariatric surgery offers superior advantages over non-surgical treatments in terms of weight loss and comorbidities associated with excess weight. The elements as mentioned above are projected to fuel the market growth for bariatric surgery devices. Furthermore, recent years have seen the development of novel data mining techniques, which show considerable promise. Intriguing insights are emerging through the application of AI-based technologies in business analytics, and these technologies are also becoming more prevalent in several healthcare subspecialties. AI algorithms have been implemented at every step of the clinical route for candidates for Bariatric Surgery, from presurgical assessment and intraoperative treatment through complications and outcome prediction. AI-enhanced technological advancements are projected to allow players to broaden their product offerings to appeal to a wider consumer base, boosting opportunities for this target market's revenue growth. However, risks associated with the treatment, such as excessive bleeding, infection, poor anesthesia reactions, blood clots, lung or breathing problems, and gastrointestinal system leakage, significantly impact the bariatric surgery device market. The risks mentioned above discourage potential patients from having bariatric surgery, which restricts the market's capacity to expand